GEHC geopolitical news & exposure
GEHC geopolitical news and exposure. GEHC appears in 170 Geopolitics Alpha notes. The newest is 08 Oct 2026, 12:45 UTC. Stored price-reaction rows cover 1 of those notes.
- Medical Devices; Immunology and Microbiology Devices; Classification of the Hematopoietic Cell Enrichment Kit
08 Oct 2026, 12:45 UTC
- Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biologics License Applications, Procedures and Requirements
08 Oct 2026, 12:45 UTC
- Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Expanded Access to Investigational Drugs for Treatment Use
08 Oct 2026, 12:45 UTC
- Determination of Regulatory Review Period for Purposes of Patent Extension; MONOFERRIC
08 Oct 2026, 12:45 UTC
- Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens
08 Oct 2026, 12:45 UTC
- Requirements for Additional Traceability Records for Certain Foods: Enforcement Policy for Certain Retail Food Establishments and Restaurants; Draft Guidance for Industry; Availability
08 Oct 2026, 12:45 UTC
- Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction
08 Oct 2026, 12:45 UTC
- Determination That LASIX (Furosemide) Oral Solution, 10 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
08 Oct 2026, 12:45 UTC
- Biotech and Pharma Industry News | BioPharma Dive
08 Oct 2026, 05:30 UTC
- 8-K - CTT PHARMACEUTICAL HOLDINGS, INC. (0001035422) (Filer)
07 Oct 2026, 21:30 UTC
- Canada’s Weston family buys Boots for $8.9bn
07 Oct 2026, 15:12 UTC
- 8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)
07 Oct 2026, 13:00 UTC
- Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Adverse Event Program for Medical Devices: (Medical Product Safety Network (MedSun))
07 Oct 2026, 12:45 UTC
- Agency Information Collection Activities; Proposed Collection; Comment Request; Channels of Trade Policy for Commodities With Residues of Pesticide Chemicals, for Which Tolerances Have Been Revoked, Suspended, or Modified by the Environmental Protection Agency Pursuant to Dietary Risk Considerations
07 Oct 2026, 12:45 UTC
- 8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)
06 Oct 2026, 20:22 UTC
- Wellwise Pharmacy Inc.; Decision and Order
06 Oct 2026, 12:45 UTC
- Arenbii Pharmacy LLC; Decision and Order
06 Oct 2026, 12:45 UTC
- Privacy Act of 1974; System of Records
06 Oct 2026, 12:45 UTC
- Mark Allen, D.D.S.; Correction to Rescission of Final Agency Action and Withdrawal of Order To Show Cause
06 Oct 2026, 12:45 UTC
- Determination That Oxandrin (Oxandrolone) Tablets, 2.5 Milligrams and 10 Milligrams, Were Withdrawn From Sale for Reasons of Safety or Effectiveness; Correction
06 Oct 2026, 12:45 UTC
- Decision and Order: Medpharm Research, LLC
06 Oct 2026, 12:45 UTC
- 8-K - Kairos Pharma, LTD. (0001962011) (Filer)
06 Oct 2026, 11:30 UTC
- Optogenics researchers win a Nobel Prize; Roche bets on Alector brain drug
05 Oct 2026, 13:57 UTC
- FDA Seeks Public Input to Support Ibogaine Research
05 Oct 2026, 13:02 UTC
- Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications; Correction
05 Oct 2026, 12:45 UTC
- Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information
05 Oct 2026, 12:45 UTC
- Determination PRALIDOXIME CHLORIDE (Autoinjector) (Pralidoxime Chloride) Solution, 600 Milligrams/2 Milliliters (300 Milligrams/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
05 Oct 2026, 12:45 UTC
- Medical Devices; General and Plastic Surgery Devices; Classification of the Focused Ultrasound System for Non-Thermal, Mechanical Tissue Ablation
05 Oct 2026, 12:45 UTC
- Issuance of Priority Review Voucher; Rare Pediatric Disease Product; FAYUVI (rebisufligene etisparvovec-hopf)
05 Oct 2026, 12:45 UTC
- Medical Devices; Cardiovascular Devices; Classification of the Hyperoxia Monitoring Device Adjunct to Pulse Oximetry
05 Oct 2026, 12:45 UTC
- Transparency in Coverage
05 Oct 2026, 12:45 UTC
- Medical Devices; Exemptions From Premarket Notification: Class II Devices; Certain Clinical Toxicology Test Systems
05 Oct 2026, 12:45 UTC
- Rafael’s Trappsol Cyclo Misses Primary Endpoint, Targets 2026 FDA Filing
04 Oct 2026, 06:01 UTC
- Notable ETF Outflow Detected - XBI, TWST, BIIB, HALO
02 Oct 2026, 15:29 UTC
- Edwards’ adjustable heart valve for children lands FDA approval
02 Oct 2026, 15:27 UTC
- Innate Pharma S.A. - Depositary Receipt Price Target Increased by 27.91% to $8.22
02 Oct 2026, 11:44 UTC
- Teva Pharmaceutical Industries Limited - Depositary Receipt Price Target Increased by 19.98% to $0.13
02 Oct 2026, 08:21 UTC
- FDA Approves First Heart Valve Designed to Grow with Children
01 Oct 2026, 19:02 UTC
- HRSA discloses manufacturers approved for revised 340B rebate pilot
01 Oct 2026, 16:08 UTC
- FDA selects first 5 participants for READI-Home initiative
01 Oct 2026, 16:04 UTC